• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

希腊药物过度使用性头痛的患病率和负担。

The prevalence and burden of medication overuse headache in Greece.

机构信息

Hellenic Headache Society, Athens, Greece.

Attikon University Hospital, Chaidari, Greece.

出版信息

Cephalalgia. 2023 Jun;43(6):3331024231184909. doi: 10.1177/03331024231184909.

DOI:10.1177/03331024231184909
PMID:37377005
Abstract

OBJECTIVE

To estimate the prevalence and burden of medication overuse headache in a representative sample of the Greek population, aged 18-70 years old.

METHODS

This is a cross-sectional descriptive observational study performed by quantitative computer-assisted telephone interviews, using a standardized 37-item questionnaire for headaches. The prevalence of medication overuse headache was estimated in the general population and compared within the groups formed by factors such as age, gender, diagnosis of headache type, prophylactic treatment used, geographical regions, social class, workdays lost and loss of productivity.

RESULTS

1197 (12.0%) participants reported headaches affecting performance out of 10,008 interviewees. The estimated prevalence of medication overuse headache in the general population was 0.7% (95% CI: 0.5-0.9). The female to male ratio was 3.6:1. The proportion of medication overuse headache was largest in the 35-54 age group, followed by the over 55 group. The Aegean islands and Crete were the regions with the highest proportion of medication overuse headache. Among participants with headaches, the proportion of medication overuse headache was 5.8% (95% CI: 4.4%-7.1%); 6.3% (95% CI: 4.7%-7.9%) among females and 4.4% (95% CI: 2.2%-6.6%) among males. In the same headache group, the proportion of medication overuse headache by prophylactic treatment for headache was 19.0% (95% CI: 9.5%-29.1%) for recipients and 5.0% (95% CI: 3.8-6.3) for non-recipients. The mean absenteeism in people with medication overuse headache was 1.0 days/month (95% CI: 0.4-1.6) and the mean presenteeism 6.3 days/month (95% CI: 3.9-8.7). The social class stratification showed a significant effect between the medication overuse headache in the sample of the general population and the C2 class, corresponding to skilled manual labour (OR: 0.7, CI: 0.5-0.9). In people with chronic migraine, and chronic tension type headache, as differentiated by the 37-item questionnaire, the proportion of medication overuse headache in the headache group estimated to be 50.5% (95% CI: 40.8%-60.1%) and 45.9%, (95% CI: 29.9%-62.0%) respectively. The group of people with acute headache medication overuse fulfilling the rest of the diagnostic criteria for medication overuse headache, except from the number of headache days per month (≥15 days/month), had a prevalence of 2.0% (95% CI: 1.75-2.30) and a proportion of 17.0% (95% CI: 14.8%-19.1%) among people with headache. In the episodic types of headache, the proportion of acute headache medication overuse was higher in the subgroup of people with high frequency episodic migraine, 24.9% (95% CI: 18.8%-31.0%), while it was 10.8% (95% CI: 8.2%-13.5%), for the low frequency episodic migraine and 8.5% (95% CI: 5.5%-10.4%), for the episodic tension type headache.

CONCLUSION

The prevalence of medication overuse headache in the general population in Greece and its proportion among the people with headache belongs to the lower part of the range of the reported literature, while the 3.6:1 female to male ratio is in agreement with it. In the same line, the impact of absenteeism and presenteeism on the workplace renders the condition alarming socio-economic health problem demanding immediate health policy planning.

摘要

目的

在希腊代表性的 18-70 岁人群中,估计药物过度使用性头痛的患病率和负担。

方法

这是一项横断面描述性观察研究,通过定量计算机辅助电话访谈进行,使用了一个标准化的 37 项头痛问卷。在一般人群中估计药物过度使用性头痛的患病率,并根据年龄、性别、头痛类型诊断、使用的预防性治疗、地理位置、社会阶层、工作日损失和生产力损失等因素进行比较。

结果

在 10008 名受访者中,有 1197 人(12.0%)报告头痛影响了他们的表现。一般人群中药物过度使用性头痛的估计患病率为 0.7%(95%可信区间:0.5-0.9)。女性与男性的比例为 3.6:1。35-54 岁年龄组药物过度使用性头痛的比例最大,其次是 55 岁以上组。爱琴海岛屿和克里特岛是药物过度使用性头痛比例最高的地区。在有头痛的参与者中,药物过度使用性头痛的比例为 5.8%(95%可信区间:4.4%-7.1%);女性为 6.3%(95%可信区间:4.7%-7.9%),男性为 4.4%(95%可信区间:2.2%-6.6%)。在同一头痛组中,接受预防性治疗的参与者中药物过度使用性头痛的比例为 19.0%(95%可信区间:9.5%-29.1%),未接受预防性治疗的比例为 5.0%(95%可信区间:3.8%-6.3%)。药物过度使用性头痛患者的平均缺勤天数为 1.0 天/月(95%可信区间:0.4-1.6),平均出勤天数为 6.3 天/月(95%可信区间:3.9-8.7)。社会阶层分层显示,在一般人群中药物过度使用性头痛的样本与熟练工人(OR:0.7,95%可信区间:0.5-0.9)对应的 C2 类之间存在显著影响。在慢性偏头痛和慢性紧张型头痛患者中,根据 37 项问卷进行区分,头痛组中药物过度使用性头痛的比例估计为 50.5%(95%可信区间:40.8%-60.1%)和 45.9%(95%可信区间:29.9%-62.0%)。符合除每月头痛天数(≥15 天/月)以外的药物过度使用性头痛诊断标准的急性头痛药物过度使用者,其患病率为 2.0%(95%可信区间:1.75-2.30),比例为 17.0%(95%可信区间:14.8%-19.1%)。在发作性头痛类型中,高频发作性偏头痛亚组的急性头痛药物过度使用比例较高,为 24.9%(95%可信区间:18.8%-31.0%),而低频发作性偏头痛为 10.8%(95%可信区间:8.2%-13.5%),发作性紧张型头痛为 8.5%(95%可信区间:5.5%-10.4%)。

结论

希腊一般人群中药物过度使用性头痛的患病率及其在头痛患者中的比例属于报告文献范围的较低部分,而 3.6:1 的女性与男性比例与之相符。同样,缺勤和出勤对工作场所的影响使这种情况成为一个令人震惊的社会经济健康问题,需要立即进行卫生政策规划。

相似文献

1
The prevalence and burden of medication overuse headache in Greece.希腊药物过度使用性头痛的患病率和负担。
Cephalalgia. 2023 Jun;43(6):3331024231184909. doi: 10.1177/03331024231184909.
2
A population-based survey for disabling headaches in Greece: Prevalence, burden and treatment preferences.基于人群的希腊头痛致残调查:患病率、负担和治疗偏好。
Cephalalgia. 2021 Jun;41(7):810-820. doi: 10.1177/0333102421989630. Epub 2021 Feb 1.
3
The prevalence of headache disorders in children and adolescents in Ethiopia: a schools-based study.埃塞俄比亚儿童和青少年头痛障碍的患病率:一项基于学校的研究。
J Headache Pain. 2020 Sep 1;21(1):108. doi: 10.1186/s10194-020-01179-2.
4
Migraine, tension-type headache and medication-overuse headache in a large population of shift working nurses: a cross-sectional study in Norway.大量轮班护士群体中的偏头痛、紧张型头痛和药物过度使用性头痛:挪威的一项横断面研究
BMJ Open. 2018 Nov 18;8(11):e022403. doi: 10.1136/bmjopen-2018-022403.
5
Primary headache disorders in the adult general population of Pakistan - a cross sectional nationwide prevalence survey.巴基斯坦成年普通人群中的原发性头痛疾病——一项全国性横断面患病率调查。
J Headache Pain. 2017 Dec;18(1):28. doi: 10.1186/s10194-017-0734-1. Epub 2017 Feb 23.
6
The prevalence of primary headache disorders in Saudi Arabia: a cross-sectional population-based study.沙特阿拉伯原发性头痛障碍的患病率:一项基于人群的横断面研究。
J Headache Pain. 2020 Feb 7;21(1):11. doi: 10.1186/s10194-020-1081-1.
7
Impact of headache disorders in Italy and the public-health and policy implications: a population-based study within the Eurolight Project.头痛疾病在意大利的影响以及公共卫生和政策意义:欧洲偏头痛项目中的一项基于人群的研究
J Headache Pain. 2015;16:100. doi: 10.1186/s10194-015-0584-7. Epub 2015 Dec 1.
8
One-year prevalence and the impact of migraine and tension-type headache in Turkey: a nationwide home-based study in adults.土耳其偏头痛和紧张型头痛的一年患病率及其影响:一项全国性基于家庭的成年人研究。
J Headache Pain. 2012 Mar;13(2):147-57. doi: 10.1007/s10194-011-0414-5. Epub 2012 Jan 14.
9
The prevalence and demographic associations of headache in the adult population of Peru: a national cross-sectional population-based study.秘鲁成年人头痛的患病率及其人口统计学关联:一项全国性横断面基于人群的研究。
J Headache Pain. 2024 Apr 3;25(1):48. doi: 10.1186/s10194-024-01759-6.
10
The prevalence of primary headache disorders in Nepal: a nationwide population-based study.尼泊尔原发性头痛疾病的患病率:一项基于全国人口的研究。
J Headache Pain. 2015;16:95. doi: 10.1186/s10194-015-0580-y. Epub 2015 Nov 10.

引用本文的文献

1
The unmet needs in management, the treatment gap and the burden of migraine in Greece: a Delphi consensus and focus group study from patients' perspective.希腊偏头痛管理方面未满足的需求、治疗差距及负担:一项基于患者视角的德尔菲共识与焦点小组研究
Front Neurol. 2025 Feb 24;16:1558014. doi: 10.3389/fneur.2025.1558014. eCollection 2025.
2
Unmet needs in the management of migraine in Greece from the perspective of medical experts: a Delphi consensus.从医学专家角度看希腊偏头痛管理中未满足的需求:德尔菲共识
Front Neurol. 2025 Feb 12;16:1556808. doi: 10.3389/fneur.2025.1556808. eCollection 2025.
3
Medication Overuse Headaches among Children-The Contribution of Migraine and TTH.
儿童药物过度使用性头痛——偏头痛和紧张性头痛的作用
Life (Basel). 2023 Sep 12;13(9):1902. doi: 10.3390/life13091902.